Treatment of drug-resistant proliferative disorders

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/197 (2006.01) A61K 31/10 (2006.01) A61K 31/18 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2593523

.alpha.,.beta.-Unsaturated sulfones, sulfoxides and sulfonamides according to Formula I: wherein Ar1, Ar2, X, n, * and R are as defined herein are useful for the treatment of proliferative disorders which are resistant to treatment by ATP-competitive kinase inhibitors.

L'invention concerne des sulfones .alpha.,.beta.-insaturées, des sulfoxydes et des sulfamides représentés par la formule générale (I). Dans cette formule, Ar1, Ar2, X, n * et R désignent des éléments décrits dans la description de la présente demande. Ces composés sont destinés au traitement de maladies proliférantes résistantes aux inhibiteurs de kinases compétitifs de l'ATP.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of drug-resistant proliferative disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of drug-resistant proliferative disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of drug-resistant proliferative disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1500904

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.